Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Alseraihy, A; McGrath, E; Niederwieser, D; Chabannon, C; Szer, J; Mohty, M; Kharfan-Dabaja, MA; Orchard, K; Schwartz, J; Rasheed, W; Koh, M; Kroger, N; Kodera, Y; El Fakih, R; Worel, N; Manson, L; Rintala, T; Tabakhi, A; Savani, B; Gergis, U; Sureda, A; Eldridge, PW; Yakoub-Agha, I; Hamadani, M; Weisdorf, D; Greinix, H; Aljurf, M.
Worldwide Network for Blood and Marrow Transplantation Special Article on Key Elements in Quality and Accreditation in Hematopoietic Stem Cell Transplantation and Cellular Therapy
TRANSPL CELL THER. 2022; 28(8): 455-462.
Doi: 10.1016/j.jtct.2022.04.003
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Greinix Hildegard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Hematopoietic stem cell transplantation (HSCT) represents an example of a highly complex and costly medical procedure with major applications in hematology and oncology. It is associated with life-threatening complica-tions and, consequently, increased demands on healthcare resources. Although improving quality is an integral component of healthcare strategic planning, drivers of quality may be variable, and there is logical debate as to what drives quality in HSCT. Moreover, HSCT programs differ in structure and availability of resources, which drive the type of transplantations provided and determine what is affordable and/or economically feasible. The complexity of HSCT procedures with involvement of different stakeholders necessitates not only regulatory frameworks, but also robust quality systems to ensure consistent standards, demonstrate transparency for regula-tors, and define what quality means within the HSCT program. In an era of escalating healthcare complexity and heightened fiscal responsibility, transparency and accountability, accreditation contributes to ensuring that care meets the highest standards and can serve as a risk mitigation strategy. Quality management has become an indispensable tool for the management of a complex medical intervention such as HSCT. It allows the trans-plantation team to monitor its activities and identify areas for continuous improvement. The Worldwide Net-work for Blood and Marrow Transplantation invited a group of international experts in HSCT and quality management to work on providing a summary document about the key elements in quality and accreditation in HSCT and highlight the foremost challenges of implementing them, with a special focus on low-and mid-dle-income economies. (c) 2022 Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.
- Find related publications in this database (Keywords)
- Hematopoietic stem cell
- transplantation
- Quality management
- Accreditation